Treatments

TriZellion’s Frankfurt center’s treatments are delivered in custom-designed consultation, hyperthermia and infusion treatment rooms, using cutting edge equipment. Read more..

Next-generation cell-based therapies are currently being used to provide solutions to a variety of conditions, including:

Tissue Repair/Damaged Organ Repair – TriZellion uses nutrition, cleansing, and autologus stem cells, combined with hormone and enzyme balancing, to repair tissue throughout the body.  In effect, this turns back the biological clock and replaces older, or dying cells. These treatments can be used to repair and rejuvenate the face, torso and other specific areas, creating tissue that is newer and more youthful.

Diabetes – is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches and other food into energy needed for daily life. Diabetes currently affects 285 million people worldwide and is expected to affect 380 million by 2025. Each year, 7 million more people develop diabetes and each year, 3.8 million deaths are attributable to the disease. Diabetes can lead to many serious health conditions, including vision loss, cardiovascular disease and renal failure. Traditional drug treatments are aimed at pushing more insulin out of the pancreas. TriZellion’s treatment approach involves lifestyle transformation along with cellular therapies designed to regenerate and heal the pancreas, kidney and blood cells and eradicate any underlying infections.

Multiple Sclerosis (MS) – is a disease that may affect any area of the brain and spinal cord. MS affects transmission of electrical signals to nerve cells and is the most common cause of chronic neurological disability in young adults. Approximately 2.5 million people worldwide have MS. TriZellion’s regenerative stem cell therapies aim to reset the patients’ immune systems using their own stem cells and fight any underlying infections or viruses.

Parkinson’s disease – is a chronic, degenerative neurological disorder that affects one in 100 people over age 60. The disorder is characterized by muscle rigidity, tremors and a slowing of physical movement. The disease primarily affects the central nervous system and leads to an impairment of bodily functions including speech and motor skills. TriZellion’s cell replacement therapy is designed to replace the neurons that degenerate in Parkinson’s and help boost the immune system to fight viruses and infections that may play a role in the disease.

Cancer – In 2007, there were over 11 million new cases of cancer diagnosed worldwide. Traditional treatments for cancer include surgery, radiation treatment and chemotherapy, all of which are invasive and can have damaging side effects. Also, they don’t address micrometastasis – the spread of secondary cancer cells too small to be clinically detected.  TriZellion uses a combinations of cellular therapies, which may include; Total Body Hyperthermia, Local Hyperthermia, Dendritic cells, NK cells, and possibly stem cells (in cases of damaged organs).  These therapies are non-invasive and enhance the patient’s own immune system to better fight cancer cells, including micrometastasis, without the harmful side effects of traditional treatments.

Hepatitis C-related liver disease – Hepatitis C is a contagious viral disease that usually leads to serious, permanent liver damage and, in many cases, death. It is estimated that 150-200 million people around the world are infected with hepatitis C – an overall incidence of around 3.3% of the population.  TriZellion uses a combinations of cellular therapies, which may include; Total Body Hyperthermia, Local Hyperthermia, Dendritic cells, NK cells, and possibly stem cells (in cases of damaged organs) which are aimed at regenerating injured liver tissue.  These therapies are non-invasive and enhance the patient’s own immune system to better fight cancer cells, including micrometastasis, without the harmful side effects of traditional treatments.

Men’s Health Issues:

Prostate cancer – occurs when cells within the prostate grow uncontrollably, creating small tumors. In most cases, prostate cancer is a relatively slow-growing cancer; however, a small percentage of patients experience more rapidly growing, aggressive forms of prostate cancer. Prostate cancer is the fifth most commonly diagnosed cancer worldwide and there have been large increases in the incidence of prostate cancer over the last 25 years. TriZellion’s Dendritic cell therapy targets diseased prostate cells.  The use of Dendritic cells was approved by the FDA in the later months of 2010.

Ofter associated with regeneration

Min constantly appears where regeneration, fertility and male potency play a role.

Erectile dysfunction (ED) – can be the result of a number of causes, including medication and disease. Worldwide, approximately 1 in 10 men suffer from some form of ED. The goal of TriZellion’s treatment is to repair damaged tissue using mesenchymal stem cells and to reactivate existing cells to improve vascularization and facilitate normal erections.

TriZellion™ does not use Embryonic, or Umbilical stem cells directly or indirectly in any of our research or treatment protocols. For additional information on any of these areas, please explore our web site, and be sure to stop by our Disclaimer page.  We look forward to receiving contact from you.